TD SYNNEX director sells 336 SNX shares at $155.79 under 10b5-1
TD SYNNEX (SNX) reported an insider transaction by a director.
Rhea-AI Filing Summary
TD SYNNEX (SNX) reported an insider transaction by a director. On 11/03/2025, the reporting person sold 336 shares of common stock at $155.79 per share, executed under a Rule 10b5-1 trading plan adopted on August 2, 2025. Following the sale, the insider beneficially owns 7,330 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 336 shares
Net Sell
1 txn
Insider
Saintil Merline
Role
Director
Sold
336 shs ($52K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 336 | $155.79 | $52K |
Holdings After Transaction:
Common Stock — 7,330 shares (Direct)
Footnotes (1)
- F1. These sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 2, 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider trade was reported for SNX?
A director sold 336 shares of TD SYNNEX common stock on 11/03/2025 at $155.79 per share.
Was the SNX trade under a 10b5-1 plan?
Yes. The sale was executed under a Rule 10b5-1 trading plan adopted on August 2, 2025.
What is the insider’s relationship to TD SYNNEX?
The reporting person is a Director of TD SYNNEX.
Were any derivative securities involved?
No derivative transactions are shown in the provided excerpt.
Was the ownership direct or indirect?
Ownership is listed as Direct (D).
AI-generated analysis. How Rhea-AI works. Not financial advice.